HK1146906A1 - Novel thermosensitive liposomes containing therapeutic agents - Google Patents

Novel thermosensitive liposomes containing therapeutic agents

Info

Publication number
HK1146906A1
HK1146906A1 HK11101026.3A HK11101026A HK1146906A1 HK 1146906 A1 HK1146906 A1 HK 1146906A1 HK 11101026 A HK11101026 A HK 11101026A HK 1146906 A1 HK1146906 A1 HK 1146906A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic agents
liposomes containing
containing therapeutic
thermosensitive liposomes
novel thermosensitive
Prior art date
Application number
HK11101026.3A
Other languages
English (en)
Inventor
Xingguo Mei
Qingwei Jiang
Weiping Yu
Original Assignee
Celsion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celsion Corp filed Critical Celsion Corp
Publication of HK1146906A1 publication Critical patent/HK1146906A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK11101026.3A 2007-11-05 2011-01-31 Novel thermosensitive liposomes containing therapeutic agents HK1146906A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2007/003128 WO2009059449A1 (en) 2007-11-05 2007-11-05 Novel thermosensitive liposomes containing therapeutic agents
PCT/CN2008/001846 WO2009062398A1 (en) 2007-11-05 2008-11-05 Novel thermosensitive liposomes containing therapeutic agents

Publications (1)

Publication Number Publication Date
HK1146906A1 true HK1146906A1 (en) 2011-07-22

Family

ID=40625343

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11101026.3A HK1146906A1 (en) 2007-11-05 2011-01-31 Novel thermosensitive liposomes containing therapeutic agents

Country Status (15)

Country Link
US (1) US8642074B2 (ja)
EP (1) EP2217209B1 (ja)
JP (1) JP5570994B2 (ja)
KR (1) KR101652126B1 (ja)
CN (1) CN101883557B (ja)
AU (1) AU2008323514B2 (ja)
BR (1) BRPI0820505A2 (ja)
CA (1) CA2704258C (ja)
ES (1) ES2689259T3 (ja)
HK (1) HK1146906A1 (ja)
MX (1) MX2010004957A (ja)
MY (1) MY151268A (ja)
RU (1) RU2497499C2 (ja)
TW (1) TWI437995B (ja)
WO (2) WO2009059449A1 (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1746976B1 (en) 2004-05-03 2017-01-11 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery
WO2012094020A1 (en) 2010-01-07 2012-07-12 Innopharma, Inc. Methods and compositions for delivery of taxanes in stable oil-in-water emulsions
CN108210463A (zh) 2011-01-28 2018-06-29 皇家飞利浦电子股份有限公司 用于局部释放亲水性前药的载体
CN102579323B (zh) * 2011-02-21 2013-06-19 舒泰神（北京）生物制药股份有限公司 一种紫杉醇醇质体凝胶剂及其制备方法
CN102688193B (zh) * 2011-03-24 2016-05-11 中国人民解放军军事医学科学院毒物药物研究所 长春碱类药物的热敏脂质体制剂及其制备方法
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
US8753674B2 (en) 2011-06-03 2014-06-17 Signpath Pharma Inc. Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
US10449193B2 (en) * 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
KR20130042905A (ko) * 2011-10-19 2013-04-29 삼성전자주식회사 엘라스틴 유사 폴리펩티드를 포함하는 리포좀 및 그의 용도
CN102552144A (zh) * 2012-01-13 2012-07-11 北京大学 一种靶向热敏脂质体
CN104203216A (zh) 2012-02-17 2014-12-10 效思因公司 热敏纳米颗粒制剂及其制备方法
ITRM20120169A1 (it) 2012-04-19 2013-10-20 Consiglio Nazionale Ricerche Dispositivo di rilascio di specie chimiche a controllo ottico
WO2013172358A1 (ja) * 2012-05-14 2013-11-21 公立大学法人大阪府立大学 機能性化合物及びその化合物を含有する分子集合体、並びにそれらを含有する組成物及びキット並びにそれらの使用
US9801874B2 (en) * 2012-11-20 2017-10-31 Spectrum Pharmaceuticals Method for the preparation of liposome encapsulated vincristine for therapeutic use
KR102109188B1 (ko) 2013-04-01 2020-05-11 삼성전자주식회사 양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도
TWI552761B (zh) * 2013-05-03 2016-10-11 博信生物科技股份有限公司 一種脂質微／奈米氣泡、及其最佳化之製備方法及製備裝置
KR20150034517A (ko) 2013-09-26 2015-04-03 삼성전자주식회사 소수성 활성 성분 및 폴리펩티드의 복합체를 포함하는 리포좀, 및 그의 용도
KR20150047336A (ko) 2013-10-24 2015-05-04 삼성전자주식회사 나노입자, 이를 제조하는 방법, 및 이의 용도
KR20150062652A (ko) 2013-11-29 2015-06-08 삼성전자주식회사 초음파 감응성 리포좀, 그를 포함한 약제학적 조성물 및 그를 이용하여 개체의 체내에 활성제를 전달하는 방법
WO2015095576A1 (en) 2013-12-18 2015-06-25 Signpath Pharma, Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
ES2942132T3 (es) 2014-06-03 2023-05-30 Signpath Pharma Inc Efecto protector de DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG y LYSOPC frente a fármacos que provocan canalopatías
US20160346221A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
TW201705941A (zh) * 2015-06-01 2017-02-16 奧托德里克有限公司 經磷脂塗覆的治療劑奈米粒子及其相關方法
WO2016205384A1 (en) * 2015-06-15 2016-12-22 The University Of Washington Multiple drug lipid nanoparticle composition and related methods for extended drug levels in blood and lymph tissue
MA42991A (fr) 2015-10-16 2018-08-22 Ipsen Biopharm Ltd Stabilisation de compositions pharmaceutiques de camptothécine
WO2017078009A1 (ja) * 2015-11-02 2017-05-11 富士フイルム株式会社 リポソーム組成物およびその製造方法
KR102181659B1 (ko) 2016-04-27 2020-11-24 사인패스 파마 인코포레이티드 약물 유발된 방실 차단의 방지
MX2021005110A (es) * 2018-11-02 2021-08-24 Tesorx Pharma Llc Quimioterapia intraperitoneal mejorada con liposomas.
CN110292563B (zh) * 2019-06-12 2021-07-16 兰州大学 基于叶酸热敏脂质体的阴离子载体诱导癌细胞凋亡的方法
WO2022042531A1 (zh) 2020-08-24 2022-03-03 清华大学 超声波搭配微气泡辅助的气球导管系统及其血管扩张方法
WO2023186923A1 (en) 2022-03-30 2023-10-05 Meta Materials Inc. Implanted agent delivery system
CN114832117A (zh) * 2022-05-20 2022-08-02 天津科技大学 一种细胞穿透肽修饰的核酸-阳离子热敏脂质体及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993754A (en) * 1974-10-09 1976-11-23 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome-encapsulated actinomycin for cancer chemotherapy
US4863739A (en) * 1987-05-19 1989-09-05 Board Of Regents, The University Of Texas System Liposome compositions of anthracycline derivatives
US4952408A (en) * 1988-05-23 1990-08-28 Georgetown University Liposome-encapsulated vinca alkaloids and their use in combatting tumors
JPH05194192A (ja) 1991-08-21 1993-08-03 Shionogi & Co Ltd 分散性の改善された温度感受性ｍｌｖ型リポソ−ム
IL113135A0 (en) 1994-03-28 1995-06-29 Daiichi Seiyaku Co Liposomes and suspensions thereof comprising multilamellar liposomes
US20050019266A1 (en) * 1997-05-06 2005-01-27 Unger Evan C. Novel targeted compositions for diagnostic and therapeutic use
WO1999052505A1 (en) 1998-04-09 1999-10-21 Nycomed Imaging A.S. Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
US6200598B1 (en) 1998-06-18 2001-03-13 Duke University Temperature-sensitive liposomal formulation
US6726925B1 (en) * 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
WO2003041682A2 (en) * 2001-11-13 2003-05-22 Celator Technologies, Inc. Lipid carrier compositions and methods for improved drug retention
EP1757270A1 (en) * 2004-04-02 2007-02-28 Italfarmaco, S.A. Liposomal formulations
TWI388344B (zh) 2005-08-23 2013-03-11 Celsion Corp 儲存奈米微粒調合物之方法

Also Published As

Publication number Publication date
EP2217209A4 (en) 2013-09-25
KR20100087030A (ko) 2010-08-02
CN101883557A (zh) 2010-11-10
US20110200665A1 (en) 2011-08-18
TW200930380A (en) 2009-07-16
CA2704258C (en) 2016-11-22
BRPI0820505A2 (pt) 2015-06-16
AU2008323514A1 (en) 2009-05-22
JP5570994B2 (ja) 2014-08-13
CN101883557B (zh) 2013-05-29
CA2704258A1 (en) 2009-05-22
RU2010123009A (ru) 2011-12-20
EP2217209A1 (en) 2010-08-18
MX2010004957A (es) 2010-08-02
AU2008323514B2 (en) 2014-06-12
TWI437995B (zh) 2014-05-21
WO2009059449A1 (en) 2009-05-14
WO2009062398A1 (en) 2009-05-22
JP2011502134A (ja) 2011-01-20
ES2689259T3 (es) 2018-11-12
MY151268A (en) 2014-04-30
EP2217209B1 (en) 2018-06-06
KR101652126B1 (ko) 2016-08-29
AU2008323514A2 (en) 2012-05-17
RU2497499C2 (ru) 2013-11-10
US8642074B2 (en) 2014-02-04

Similar Documents

Publication Publication Date Title
HK1146906A1 (en) Novel thermosensitive liposomes containing therapeutic agents
EP2117311A4 (en) THERAPEUTICS
EP2211620A4 (en) THERAPEUTIC COMPOUNDS
HRP20130041T8 (en) Therapeutic agents
GB0723747D0 (en) Therapeutic agents
GB0813087D0 (en) Therapeutic compounds
GB0716532D0 (en) Therapeutic compounds
EP2164324A4 (en) THERAPEUTIC COMPOUNDS
GB0724340D0 (en) Novel Therapeutic Agents
GB0710981D0 (en) New Therapeutic use
EP2185568A4 (en) THERAPEUTIC COMPOUNDS
GB0702862D0 (en) Therapeutic compounds
GB0723748D0 (en) Therapeutic agents
GB0808690D0 (en) Therapeutic use
GB0708188D0 (en) Therapeutic compounds
GB0715600D0 (en) New therapeutic agents
GB0723749D0 (en) Therapeutic agents
GB0725030D0 (en) Therapeutic agents
GB0723751D0 (en) Therapeutic agents
GB0708186D0 (en) Therapeutic compounds
GB0717572D0 (en) Therapeutic compounds
GB0713865D0 (en) Therapeutic compounds
GB0707359D0 (en) Therapeutic compounds
GB0717571D0 (en) Therapeutic compounds
GB0722401D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231107